Found 13 matching trials
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
PHASE2A randomized, double-blind, placebo-controlled parallel group 3-arm study a...
Location
Bioxcel Clinical Research Site
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
PHASE3In this study, an investigational medication named BXCL501 is being tested ...
Location
BioXcel Clinical Research Site 113
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
PHASE3This is a definitive study to support the safety and efficacy evaluation of...
Location
BioXcel Clinical Research Site
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
PHASE4This is an in-clinic, single arm, open-label study assessing tachyphylaxis,...
Location
BioXcel Clinical Research Site
Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
PHASE2This open-label study will utilize treatment with BXCL501 in order to asses...
Location
BioXcel Clinical Research Site 103
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
PHASE3A study to determine the safety and efficacy of BXCL501 dosing for episodes...
Location
BioXcel Clinical Research Site
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
PHASE4This is a single-arm pilot study to examine the impact of BXCL501 (sublingu...
Location
Multiple Locations
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
PHASE1This is an adaptive Phase 1b/2 trial design. It is randomized, double-blind...
Location
BioXcel Clinical Research Site
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
PHASE1This is a two-stage adaptive Phase Ib trial design, that will identify two ...
Location
BioXcel Clinical Research Site
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
PHASE3This is a definitive study to support the safety and efficacy evaluation of...
Location
BioXcel Clinical Research Site